$24.25
-0.16-0.63%
Últ. Act.: Oct 21, 10:40 AM
$24.41
N/A
Alto Neuroscience (ANRO) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.76 | $-0.52 | $-0.53 | $-0.65 |
| Actual | $-0.65 | $-0.80 | $-0.45 | $-0.52 |
| Surprise | +14.5% | -53.8% | +15.1% | +20.0% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | — | — | — | — |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.68 | $-0.71 | $-0.73 | $-0.75 |
| Revenue | ||||
| Consensus | — | — | — | — |
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q2 | Aug 12, 2026 | $-0.65 | $-0.76 | 14.5 % |
| Q1 | May 13, 2026 | $-0.80 | $-0.52 | -53.8 % |
| Q4 | Mar 16, 2026 | $-0.45 | $-0.53 | 15.1 % |
| Q3 | Nov 12, 2025 | $-0.52 | $-0.65 | 20.0 % |